We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+5.3%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$342B
AUM Growth
+$4.99B
(+1.5%)
Cap. Flow
-$5.86B
Cap. Flow
% of AUM
-1.71%
Top 10 Holdings %
Top 10 Hldgs %
31.71%
Holding
3,487
New
211
Increased
1,344
Reduced
1,316
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.03B |
| 2 |
Valero Energy
VLO
|
+$273M |
| 3 |
Progressive
PGR
|
+$259M |
| 4 |
Advanced Micro Devices
AMD
|
+$256M |
| 5 |
O'Reilly Automotive
ORLY
|
+$232M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$466M |
| 2 |
NVIDIA
NVDA
|
+$435M |
| 3 |
Intel
INTC
|
+$426M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$389M |
| 5 |
Merck
MRK
|
+$354M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.78% |
| 2 | Financials | 11.71% |
| 3 | Healthcare | 11.09% |
| 4 | Consumer Discretionary | 10.64% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Alto Neuroscience
ANRO
$1.11B
| $403K | ﹤0.01% |
+37,699
| New | +$491K |
|
3027
ThredUp
TDUP
$422M
| $403K | ﹤0.01% |
237,039
+18,809
| +9% | +$34.3K |
|
|
LLAP
3028
DELISTED
Terran Orbital Corporation
LLAP
| $403K | ﹤0.01% |
491,044
+92,626
| +23% | +$99.3K |
|
|
LENZ
3029
LENZ Therapeutics
LENZ
$168M
| $400K | ﹤0.01% |
+23,130
| New | +$404K |
|
3030
Global Water Resources
GWRS
$219M
| $400K | ﹤0.01% |
33,038
| – | – |
|
3031
Vesta Real Estate
VTMX
$3.18B
| $399K | ﹤0.01% |
+13,311
| New | +$465K |
|
3032
Harvard Bioscience
HBIO
$29.2M
| $399K | ﹤0.01% |
14,000
| – | – |
|
3033
BayCom
BCML
$333M
| $399K | ﹤0.01% |
19,606
| – | – |
|
3034
Fidelity D&D Bancorp
FDBC
$317M
| $398K | ﹤0.01% |
9,080
| – | – |
|
3035
First Internet Bancorp
INBK
$255M
| $398K | ﹤0.01% |
+14,717
| New | +$445K |
|
3036
NI Holdings
NODK
$320M
| $395K | ﹤0.01% |
25,786
| – | – |
|
|
SCPH
3037
DELISTED
scPharmaceuticals
SCPH
| $394K | ﹤0.01% |
90,503
| – | – |
|
3038
BlackRock MuniHoldings Fund
MHD
$606M
| $392K | ﹤0.01% |
32,260
+913
| +3% | +$10.7K |
|
3039
Foghorn Therapeutics
FHTX
$360M
| $390K | ﹤0.01% |
67,866
+13,903
| +26% | +$82.8K |
|
3040
Kenon Holdings
KEN
$3.45B
| $389K | ﹤0.01% |
15,611
| – | – |
|
3041
Akebia Therapeutics
AKBA
$252M
| $388K | ﹤0.01% |
+380,535
| New | +$470K |
|
3042
eGain
EGAN
$201M
| $385K | ﹤0.01% |
60,949
| – | – |
|
|
TEAD
3043
Teads Holding Co
TEAD
$66.9M
| $384K | ﹤0.01% |
77,142
| – | – |
|
|
NOA
3044
North American Construction
NOA
$395M
| $383K | ﹤0.01% |
19,889
| – | – |
|
3045
NET Power
NPWR
$134M
| $383K | ﹤0.01% |
+38,986
| New | +$414K |
|
|
PHLT
3046
DELISTED
Performant Healthcare Inc
PHLT
| $381K | ﹤0.01% |
131,271
| – | – |
|
3047
Riskified
RSKD
$716M
| $381K | ﹤0.01% |
59,563
| – | – |
|
3048
Arteris
AIP
$1.38B
| $379K | ﹤0.01% |
+50,513
| New | +$385K |
|
|
SEZL
3049
Sezzle
SEZL
$3.97B
| $379K | ﹤0.01% |
+25,776
| New | +$300K |
|
3050
Korro Bio
KRRO
$195M
| $378K | ﹤0.01% |
+11,164
| New | +$617K |
|
Similar funds
VFT
Nuveen's Q2 2024 Portfolio in Review
As of Q2 2024, Nuveen held 3,487 positions worth $342B, up 1.5% from $337B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Nuveen's Q2 2024 filing shows 211 new, 1,344 increased, 1,316 reduced and 159 closed positions. Its largest new stake was GE Vernova: 595,802 shares worth $102M. The largest sale was Meta Platforms (Facebook), an estimated $466M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q2 2024 buy was GE Vernova: 595,802 shares worth $102M.
- Nuveen added most to Apple in Q2 2024, an estimated $1.03B increase.
- Nuveen's biggest Q2 2024 reduction was Meta Platforms (Facebook), cutting an estimated $466M.
- Nuveen fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $389M.
- Nuveen's ten largest holdings make up 32% of its $342B portfolio in Q2 2024.
- Nuveen opened 211 new positions and closed 159 in Q2 2024.
- Nuveen's portfolio value rose 1.5% quarter-over-quarter to $342B.
Based on Nuveen's 13F filing for Q2 2024, filed 9 Aug 2024.